Methods for using elk-L to enhance neuronal survival

Details Methods for using elk-L to enhance neuronal survival Methods for using elk-L to enhance neuronal survival

1998-03-16

2003-04-01

Gambel, Phillip (Department: 1644)

Drug, bio-affecting and body treating compositions

Lymphokine

C424S130100, C424S134100, C424S184100, C424S185100, C424S192100, C530S350000, C530S351000, C530S387100, C530S387300

Reexamination Certificate

active

06540992

ABSTRACT:

BACKGROUND OF THE INVENTION
The cell surface protein designated elk is a member of a family of proteins known as the tyrosine kinase receptors. Proteins of this family have an intrinsic kinase activity that is activated upon ligand binding. A partial clone of elk was first discovered in a rat brain cDNA expression library that was screened for proteins expressing tyrosine kinase activity (Letwin et al.,
Oncogene
3:621, 1988). Later, a composite sequence spanning the entire elk coding region was derived from partial clones isolated from a rat brain cDNA library and a rat cerebellar brain library using the partial clone as a probe (Lhotak et al.,
Mol. Cell. Biol
. 11:2496, 1991). The elk protein is very closely related to a number of other receptor tyrosine kinases, including hek (Boyd et al.
J. Biol. Chem
. 267:3262, 1992 and Wicks et al.
Proc. Natl. Acad. Sci. USA
89:1611, 1992); the hek homologs mek4 and cek4 (Sajjadi et al.
New Biol
. 3:769, 1991); eek (Chan et al.
Oncogene
6:1057, 1991); erk (Chan et al. supra.), eck (Lindberg et al.
Mol. Cell. Biol
. 10:6316, 1990); cek5 (Pasquale, E. B.
Cell Regulation
2:523, 1991); and eph (Hirai et al.
Science
238:1717, 1987). The proteins of this subfamily are related not only in their cytoplasmic domains, but also in their extracellular domains, which are 41 to 68% identical. Interestingly, the tissue distributions of these various receptors are diverse. For example, expression of elk mRNA has been shown to be limited to testis and brain (Lhotak et al., supra), whereas eck is found not only in these same two tissues but in lung, intestine, kidney, spleen, ovary, and skin as well.
Ligands for the receptor tyrosine kinases are a diverse group of proteins that affect the growth, differentiation, and survival of cells expressing the receptors. To date, no ligand for elk has been discovered. Identification of the putative ligand would prove useful in investigating the nature of cellular processes that might be regulated by the elk protein.
SUMMARY OF THE INVENTION
The present invention provides a novel cytokine designated elk ligand (elk-L) that binds to the rat cell surface receptor known as elk. The present invention also provides isolated DNA encoding the elk-L protein, expression vectors comprising the isolated DNA, and a method for producing elk-L by cultivating host cells containing the expression vectors under conditions appropriate for expression of the elk-L protein. Antibodies directed against the elk-L protein or an immunogenic fragment thereof are also disclosed.


REFERENCES:
Meldrum et al. Trends. Pharmacol. Sci. 11: 379, 1990.*
Rudinger, J. Peptide Hormones. Ed. Parsons, J.A., Univ. Park Press. Baltimore, pp. 1-7, 1976.*
Jackowski, A. Brit. J. Neurosurg. vol. 9, pp. 303-317, 1995.*
De Kyser et al. Trends Neurosci. vol. 22, pp 535-540, 1999.*
Doppenberg, et al. Ann. N. Y. Acad. Sci. vol. 825, pp 305-322, 1997.*
Ngo et al. The Protein Folding Problem and Tertiary Structure Prediction. K. Merz & S. Le Grand Eds., Birkhauser Boston, pp 491-495, 1994.*
Abbott, N. Joan, “Inflammatory Mediators and Modulation of Blood-Brain Barrier Permeability”Cell Mol. Neurobiol. 20: 131-147 [2000].
Barinaga, Marcia, “New Leads to Brain Neuron Regeneration”Science282:1018-1019[1998].
Blandini et al., “Glutamate and Parkinson's Disease”Mol. Neurobiol. 12:73-94 [1996].
Gallo and Letourneau, “Localized Sources of Neurotrophins Initiate Axon”J. Neurosci. 18:5403-5414 [1998].
Greenwood, J., “Mechanisms of blood-brain barrier breakdown”Neuroradiology33:95-100 [1991].
Herzog and Otto, “Regeneration of olfactory receptor neurons following chemical lesion: time course and enhancement with growth factor administration”Brain Res. 849:155-161 [1999].
Holm and Isacson, “Factors intrinsic to the neuron can induce and maintain its ability to promote axonal outgrowth: a role for BCL2”Tins22(6):269-273 [1999].
Leventhal et al. “Cyclosporin A Protects Striatal Neurons In Vitro and In Vivo From 3-Nitropropionic Acid Toxicity”,J. Comp. Neurol. 425:471-478[2000].
Rodriguez, et al., “Subthalamic Nucleus-mediated Excitotoxicity in Parkinsom's Disease: A Target for Neuroprotection”Annals of Neurology44:S175-S188 [1998].
Unterberg et al,, “Permeability and vasomotor response of cerebral vessels during exposure to arachidonic acid”Acta Neuropathologica73:209-219 [1987].
Williams et al., “Neuroprotective Efficacy and Therapeutic Window of the High-Affinity N-Methyl0D0aspartate Antagononist Conantokin-G: In Vitro (Primary Cerebellar Neurons) and In Vivo (Rat Model of Transient Focal Brain Ischemia) Studies”J. Pharmacol. Exp. Ther. 294:378-386[2000].

Affiliated with

Also associated with

Rating

Methods for using elk-L to enhance neuronal survival does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for using elk-L to enhance neuronal survival, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for using elk-L to enhance neuronal survival will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3114604